white rice, white bread, and processed snacks are at the top of the list
Withdrawal symptoms can include Increased appetite Decreased satiety Elevated blood sugar levels Weight gain Elevated blood pressure and other cardiovascular changes A study from a 2022 clinical trial that tested semaglutide treatment for weight loss found that participants had regained about two-thirds of their initial weight loss on average, and many patients also experienced raised blood pressure levels
Here is the Wegovy semaglutide dosage chart for weight loss: Month 1 (Weeks 1-4): 0.25 mg per week Month 2 (Weeks 5-8): 0.5 mg per week Month 3 (Weeks 9-12): 1.0 mg per week Month 4 (Weeks 13-16, or more): 1.7 mg per week Month 5 and beyond (Week 17+): 2.4 mg per week (Maintenance dose) This schedule is the one used in the major semaglutide clinical trials that resulted in weight loss
However, as mentioned earlier, T2D and MDS-related TOD are preventable, and effective measures must be taken to prevent the occurrence of diabetes, such as the prevention and treatment of preobesity and obesity and MASLD, which will greatly reduce the occurrence of T2D
